Clinical Trial Update: Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating BuEAM conditioning (Busulfan, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation for non-Hodgkin lymphoma (e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Melphalan (Melphalan)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN